Maisonneuve-Rosemont Hospital Université de Montréal

Multiple myeloma

Autologous transplant

66-69 years

≤ 65 years

Inclusions

Exclusion criteria

Treatment after autologous tranplant # 1

Autologous transplant followed by sibling allogeneic nonmyeloablative transplant

≤ 65 years

Autologous transplant followed by unrelated donor allogeneic nonmyeloablative transplant

≤ 50 years

Renal insufficiency

Biphosphonates

Autologous stem cells mobilization

Patients will bet mobilized with cyclophosphamide 1.5g/m2. Patients who have not achieved partial response before transplant will be mobilized with cyclophosphamide 3g/m2 if physically fit.